It isn't easy to find steady and reliable dividend payers in the pharmaceutical industry. The key reason is simple: Drug development is a frequently laborious and expensive process that can swallow vast amounts of capital.Yet there is a clutch of companies at the top of the industry not only paying distributions regularly, but also lately increasing them on a consistent basis.Two of these, Bristol Myers Squibb (BMY -1.41%) and Eli Lilly (LLY -1.79%), just declared dividend raises. What's more, since the new ...